These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21094062)

  • 1. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
    Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
    Bähr O; Hermisson M; Rona S; Rieger J; Nussbaum S; Körtvelyessy P; Franz K; Tatagiba M; Seifert V; Weller M; Steinbach JP
    Acta Neurochir (Wien); 2012 Feb; 154(2):229-35; discussion 235. PubMed ID: 21909835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in the treatment of neonatal seizures: a pilot study.
    Fürwentsches A; Bussmann C; Ramantani G; Ebinger F; Philippi H; Pöschl J; Schubert S; Rating D; Bast T
    Seizure; 2010 Apr; 19(3):185-9. PubMed ID: 20133173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
    Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
    Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O; Chang E; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous levetiracetam for acute seizure management in preterm neonates.
    Khan O; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2013 Nov; 49(5):340-3. PubMed ID: 23921284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.
    Rüegg S; Naegelin Y; Hardmeier M; Winkler DT; Marsch S; Fuhr P
    Epilepsy Behav; 2008 Apr; 12(3):477-80. PubMed ID: 18291724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of levetiracetam in the management of seizures in neonates.
    Sedighi M; Asadi F; Moradian N; Vakiliamini M; Moradian M
    Neurosciences (Riyadh); 2016 Jul; 21(3):232-5. PubMed ID: 27356654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
    Maitre NL; Smolinsky C; Slaughter JC; Stark AR
    J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.